AI in Drug Discovery Market Size, Demand, Analytical Overview, Comprehensive Analysis, Segmentation, Competitive Landscape 2035

Date of Publication: 29 May 2025 - The newly released report titled ‘‘AI in Drug Discovery Market ’ offers a structured analysis of the current state and future outlook of the global market. Covering historical trends and future projections from 2025 to 2035, the study evaluates how the market size has shifted over time and what lies ahead in terms of growth and development. The report focuses on evidence-based trends, providing insights into demand shifts, market structure, and broader industry patterns.

The AI in drug discovery market size is estimated to grow from USD 1.8 billion in 2024 to reach USD 2.9 billion in 2025 and USD 13.4 billion by 2035, representing a higher CAGR of 16.5% during the forecast period.. The report assesses this growth by examining real-world data, strategic decisions made by key companies, and movement across regional markets. Rather than making speculative forecasts, it presents information in a way that supports grounded business decision-making and planning.

Source of Information- https://www.rootsanalysis.com/reports/ai-based-drug-discovery-market.html

The research investigates key elements influencing the market and offers a detailed breakdown of major operational categories. It explores business expansion efforts, investment themes, and product distribution strategies used across the industry. Readers are provided with a neutral overview of the ‘AI in Drug Discovery Market forecast, grounded in verified insights rather than promotional narratives.

Distribution by DrugDiscovery Steps

Target identification / validation

Hit generation / lead identification

Lead optimization

Distribution by TherapeuticArea

Oncological disorders

CNS disorders

Infectious diseases

Respiratory disorders

Cardiovascular disorders

Endocrine disorders

Gastrointestinal disorders

Musculoskeletal disorders

Immunological disorders

Dermatological disorders

Others

Key Geographical Region

North America

Europe

Asia-Pacific

Latin America

Middle East and North Africa

Rest of the World

Key Companies Profiled

Aiforia Technologies

Atomwise

BioSyntagma

Chemalive

Collaborations Pharmaceuticals

Cyclica

DeepMatter

Recursion

InveniAI

MAbSilico

Optibrium

Recursion Pharmaceuticals

Sensyne Health

Valo Health

The report includes a dedicated analysis of major players contributing to the ‘AI in Drug Discovery Market growth. Some of the top companies in ‘AI in Drug Discovery include Aiforia Technologies, Atomwise, BioSyntagma, Chemalive, Collaborations Pharmaceuticals, Cyclica, DeepMatter, Recursion, InveniAI, MAbSilico, Optibrium, Recursion Pharmaceuticals, Sensyne Health, Valo Health.

These organizations have been profiled in terms of their operational scale, product offerings, and strategic initiatives. Their positions in regional and global markets are discussed with reference to product performance, market engagement, and business continuity strategies. The report highlights how these players have shaped the market over time, offering insight into their long-term direction and business focus.

The study also touches on a range of external factors such as policy changes, access to distribution networks, and market regulations. These elements play a role in shaping the trajectory of the market for ‘AI in Drug Discovery and influence how companies develop and implement their strategic approaches. Regional patterns, investment outlooks, and evolving pricing structures are also evaluated to provide a well-rounded view of the ‘AI in Drug Discovery industry share.

Strategic movements such as partnerships, acquisitions, and new market entries are assessed as part of the broader market landscape. The report draws attention to how businesses are responding to demand patterns, operating in changing environments, and aligning with regional policies.

Research Methodology
The report has been developed using a combination of primary and secondary research techniques. Company websites, SEC filings, investor presentations, public records, and interviews with industry participants have been utilized to build a credible and balanced dataset. These methods have ensured accurate findings and insights, enabling stakeholders to better navigate the ‘AI in Drug Discovery Market and make informed decisions.

To learn more about the report or to request a customized version tailored to your business requirements, feel free to get in touch with our team. We’re here to assist with further details and support your strategic planning initiatives.

About Roots Analysis

Roots Analysis is a global leader in market research, competitive intelligence and consulting services across industries. The leading market research company – Roots Analysis has different product offerings. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, and venture and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serving our clients in the best possible way.

Contact Details

Roots Analysis

Gaurav Chaudhary

+1 (857) 387 7999
+44 (748) 188 1310

Gaurav.chaudhary@rootsanalysis.com

Website: https://www.rootsanalysis.com/